Zag Bio

Cambridge, Massachusetts, United States · Biotechnology, Health Care · 35 employees

Zag Bio™ is a biotechnology company pioneering thymus-targeted medicines. It focuses on the development of systemic therapeutics to deliver self-antigens directly to the thymus, aiming to induce central tolerance for treating autoimmune diseases. The lead program is advancing toward clinical trials for Type 1 diabetes, with ongoing discovery efforts for other autoimmune conditions. Zag Bio's techn

See plans & pricing → Track Zag Bio’s funding, hiring, and signals — with verified contacts — on Fundz.